Ellen M Shelly1, Rodolfo Acuna-Soto2, Kacey C Ernst1, Charles R Sterling3, Heidi E Brown1. 1. University of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, AZ. 2. Universidad Nacional Autónoma de México, Mexico City, Mexico. 3. University of Arizona, School of Animal and Comparative Biomedical Sciences, Tucson, AZ.
Abstract
OBJECTIVE: Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. METHODS: We summarized age and sex differences for Chagas cases and mortality for 1995-2013 and 1982-2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. RESULTS: Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25-44 years (47.3%). Mortality was highest in adults aged ≥45 years (423/495, 85.5%). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. CONCLUSION: While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.
OBJECTIVE:Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. METHODS: We summarized age and sex differences for Chagas cases and mortality for 1995-2013 and 1982-2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. RESULTS: Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25-44 years (47.3%). Mortality was highest in adults aged ≥45 years (423/495, 85.5%). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. CONCLUSION: While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.
Authors: V M Monteón-Padilla; N Hernández-Becerril; C Guzmán-Bracho; J L Rosales-Encina; P A Reyes-López Journal: Arch Med Res Date: 1999 Sep-Oct Impact factor: 2.235
Authors: Louis V Kirchhoff; Patricia Paredes; Abel Lomelí-Guerrero; Mario Paredes-Espinoza; Carlos S Ron-Guerrero; Manuel Delgado-Mejía; José G Peña-Muñoz Journal: Transfusion Date: 2006-02 Impact factor: 3.157
Authors: C Guzmán Bracho; L García García; J Floriani Verdugo; S Guerrero Martínez; M Torres Cosme; C Ramírez Melgar; O Velasco Castrejón Journal: Rev Panam Salud Publica Date: 1998-08
Authors: Jennifer M Manne; Callae S Snively; Janine M Ramsey; Marco Ocampo Salgado; Till Bärnighausen; Michael R Reich Journal: PLoS Negl Trop Dis Date: 2013-10-17
Authors: Sarah M Bartsch; Cameron M Avelis; Lindsey Asti; Daniel L Hertenstein; Martial Ndeffo-Mbah; Alison Galvani; Bruce Y Lee Journal: PLoS Negl Trop Dis Date: 2018-11-05
Authors: Bruce Y Lee; Sarah M Bartsch; Laura Skrip; Daniel L Hertenstein; Cameron M Avelis; Martial Ndeffo-Mbah; Carla Tilchin; Eric O Dumonteil; Alison Galvani Journal: PLoS Negl Trop Dis Date: 2018-03-19